Jennifer Kayden Lee's Net Worth

$2.83 Million

Estimate Recalculated Nov 11, 2024 01:40PM EST

Who is Jennifer Kayden Lee

Jennifer Kayden Lee has an estimated net worth of $2.83 Million. This is based on reported shares across multiple companies, which include RHYTHM PHARMACEUTICALS, INC., and Krystal Biotech, Inc..

SEC CIK

Jennifer Kayden Lee's CIK is 0001801372

Past Insider Trading and Trends

2023 was Jennifer Kayden Lee's most active year for acquiring shares with 11 total transactions. Jennifer Kayden Lee's most active month to acquire stocks was the month of January. 2023 was Jennifer Kayden Lee's most active year for disposing of shares, totalling 21 transactions. Jennifer Kayden Lee's most active month to dispose stocks was the month of January. 2023 saw Jennifer Kayden Lee paying a total of $245,398.40 for 106,507 shares, this is the most they've acquired in one year. In 2024 Jennifer Kayden Lee cashed out on 46,862 shares for a total of $1,465,939.97, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

RHYTHM PHARMACEUTICALS, INC.

EVP, Head North America
Updated Mar 22, 2024
Form 4
-72.69%
-18.23K
$38.77
-$707.00K
Mar 22, 2024
6.85K
Sale
Mar 20
Form 4
-38.21%
-15.52K
$39.22
-$608.50K
Mar 19, 2024
25.09K
Sale
Mar 19
Form 4
1,791.45%
122.75K
Feb 21, 2024
129.60K
Grant
Feb 16
Form 4
-9.42%
-1.64K
$50.80
-$83.21K
Feb 13, 2024
15.76K
Sale
Feb 09 - Feb 13
Form 4
-8.27%
-1.49K
$45.06
-$67.23K
Feb 05, 2024
16.56K
Sale
Feb 01
Form 4
-22.76%
-13.68K
$19.40
-$356.01K
Nov 16, 2023
46.41K
Sale
ScheduledNov 14
Form 4
-13.22%
-9.15K
$17.63
-$198.07K
Nov 13, 2023
60.09K
Sale
ScheduledNov 08 - Nov 09
Form 4
-0.12%
-80.00
$17.40
-$1.70K
Nov 07, 2023
69.24K
Sale
ScheduledNov 03
Form 4
-8.17%
-6.17K
$17.43
-$142.23K
Sep 07, 2023
69.32K
Sale
Sep 05
Form 4
-14.63%
-12.94K
$15.52
-$243.61K
Aug 09, 2023
75.49K
Sale
Aug 07 - Aug 09
Form 4
-6.59%
-635.00
$26.87
-$17.06K
Feb 14, 2023
9.00K
Sale
ScheduledFeb 11 - Feb 14
Form 4/A
-25.36%
-1.20K
$27.51
-$33.12K
Feb 14, 2023
3.54K
Sale
ScheduledFeb 09
Form 4
-7.92%
-1.19K
$27.66
-$32.97K
Feb 13, 2023
13.87K
Sale
ScheduledFeb 09
Form 4
64.95K
Feb 03, 2023
64.95K
Grant
Feb 01
Form 4
-8.89%
-722.00
$6.10
-$4.40K
Feb 15, 2022
7.40K
Sale
ScheduledFeb 11 - Feb 15
Form 4
96.25K
Feb 11, 2022
96.25K
Grant
Feb 09
Form 4
56.88K
Feb 16, 2021
56.88K
Grant
Feb 11
Form 4
100.00K
Nov 10, 2020
100.00K
Grant
Nov 09
Form 3
Nov 10, 2020
Showing 19 results

Krystal Biotech, Inc.

Chief Commercial Officer
Updated Feb 04, 2020
Form 4
125.00K
Feb 04, 2020
125.00K
Grant
Jan 31
Form 3
Jan 31, 2020
Showing 2 results